Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Sophie R. Vaccarino, BScH
JCP
Systematic Review
Cognitive Effects of Ketamine in Depression
January 4, 2022
The cognitive effects of ketamine have not been thoroughly investigated in depressed populations. This systematic review sought to determine the objective neurocognitive effects of ketamine in individuals with unipolar...
Sophie R. Vaccarino
,
Fathima Adamsahib
,
Roumen V. Milev
, et al
JCP
Original Research
Procognitive Effects of Therapeutic Agents in MDD
July 21, 2020
What is the efficacy of antidepressants and other agents for treating cognitive impairment in adults with major depressive disorder? Review available research in this CME journal activity.
Michelle J. Blumberg
,
Sophie R. Vaccarino
,
Shane J. McInerney
JCP
Review Article
Procognitive Effects of Modafinil in Depression
October 8, 2019
Depression can cause notable cognitive deficits. Read this review article to learn about the efficacy of the wakefulness-promoting drug modafinil in the treatment of cognitive impairments associated with major...
Sophie R. Vaccarino
,
Shane J. McInerney
,
Sidney H. Kennedy
, et al